Area of research
Molecular Biology · Oncology
Research interest
Research focused on Bladder cancer and Cancer research, with related work in Cancer, Carcinogenesis, microRNA. Notable publications include 'Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas', 'miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway', and 'The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer'.
The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer
Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform
miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway
MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene
The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer
Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas